Researchers link bacterial strain in animal gut to maternal behaviour

Findings provide ‘more evidence that there is a gut-brain connection’

US biotech accuses Irish pharma of infringing patent protection

Genentech says Dublin-based Amgen’s cancer treatment drug is infringing its patent

GSK buys US cancer drugmaker Tesaro for hefty $5.1bn

GSK has fallen behind rivals in producing multibillion-dollar blockbusters

Valitacell ramps up its targeting of big pharma

UCD-based Irish biological drug firm lists GE and MedImmune among clients

Call to lengthen cancer drug patent to cut cost

Price of groundbreaking new cancer drugs could be reduced, says Dr Vishva Dixit

Almac Discovery agrees drug development deal with Genentech

Craigavon based company will initially receive an upfront payment of more than £9m

Roche to buy US drugmaker InterMune for $8.3 billion

US entity unprofitable biotech that’s awaiting US approval of its biggest drug

The man whose map is the future

Disruptive technology, logic shifts, crazy ideas: these are survival tools and moral compasses for Peter Diamandis

More firms weigh IPOs as biotech fever reaches Europe

Top candidates for a share sale include Swiss firms AC Immune and Molecular Partners

Roche chairman to follow predecessor’s tight-fisted approach toward acquisitions

Company shelved $6.7bn bid for gene-sequencing firm Illumina in 2012 over cost

Google to form new company to tackle ageing and its side effects

Roche halts diabetes drug trial

Cancer drug specialist says it will review R&D programme after second high profile setback for its pipeline

Spurned suitor still chasing elusive Elan takeover deal

The chief executive of Royalty Pharma is still keen to talk to Ireland’s largest indigenous pharma group about making a deal work